Stay updated on JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Sign up to get notified when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.

Latest updates to the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows a new revision tag (v3.4.2) replacing the previous v3.4.1 and does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing Revision: v3.4.0. This is a minor version update with no visible changes to study details or site functionality.SummaryDifference0.1%

- Check27 days agoChange DetectedUI and text updates include adding a 'Show glossary' feature, capitalization tweaks to several labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a new page revision label 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4. No study content or layout changes were observed.SummaryDifference0.1%

- Check62 days agoChange DetectedFooter area updated: added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this appears to be a UI/maintenance update and does not modify study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.